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Introduction
Over recent years, the field of biomaterials has made sig-
nificant progress in the search for functional and bioactive 
materials for bone repair procedures and regeneration. 
Current clinical approaches for bone defect treatments 
involve the grafting of autologous (autograft), homolo-
gous (allograft), and heterologous (xenograft) bone.1 
Among them, autografts are considered the gold standard 
because they are biocompatible and non-immunogenic, 
and they contain every essential component to trigger oste-
oinduction, osteogenesis, and osteoconduction. As an 
autologous bone transplant involves the harvesting of bone 
from the patient’s body, however, it relies on a relatively 
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Background: Great interest has recently been focused on tooth and tooth derivatives as suitable substrates for the 
treatment of alveolar bone defects. Here, we propose the use of demineralized baby teeth (BT) as potential grafting 
materials for bone augmentation procedures.
Methods: Particles of human BT (Ø < 1 mm) were demineralized by means of a chemical/thermal treatment. 
Demineralized BT particles were thoroughly characterized by scanning electron microscopy/energy dispersive X-ray 
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enzyme-linked immunosorbent assays (ELISA) to quantify collagen and bone morphogenetic protein-2 (BMP-2) protein 
contents. The response of SAOS-2 cells to exogenous BMP-2 stimulation was evaluated to identify the minimum BMP-2 
concentration able to induce osteodifferentiation in vitro (alkaline phosphatase (ALP) activity).
Results: The demineralization treatment led to a dramatic decrease in relative Ca and P content (%) of ≈75% with respect 
to the native BT particles, while preserving native protein conformation and activity. Interestingly, the demineralization 
process led to a rise in the bioavailability of BMP-2 in BT particles, as compared to the untreated counterparts. The 
BMP-2 content found in demineralized BT was also proved to be very effective in enhancing ALP activity, thus in the 
osteodifferentiation of SAOS-2 cells in vitro, as confirmed by cell experiments performed upon exogenously added 
BMP-2.
Conclusions: In this study we demonstrate that the BMP-2 content found in demineralized BT is very effective in 
inducing cell osteodifferentiation, and strengthens the idea that BTs are very attractive bioactive materials for bone-
grafting procedures.
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limited availability of tissue, and it is sometimes associ-
ated with a significant donor site injury and morbidity. In 
this context, allografts may represent a viable alternative 
to autografts in bone-grafting procedures. Unfortunately, 
allogenic grafts are associated with the risks of immunore-
actions and transmission of infections, and they come with 
substantial cost issues. As an alternative, a wide range of 
biomaterials has been envisioned as scaffolds to foster and 
support tissue formation in vitro and in vivo.2,3 They 
include metals,4 ceramics,5 as well as synthetic,6,7 and nat-
ural polymers such as collagen and some composites.8–10
In recent years, tooth11–13 and tooth-derived materi-
als14,15 have come to the fore as very promising substrates 
for bone regeneration because they closely resemble bone 
tissue, in terms of matrix composition and topography. It is 
of note that, unlike bone autografts/allografts, which are 
rarely available at need, teeth are extracted every day and 
customarily discarded as waste.
Dentin has recently gained growing interest as a poten-
tial osteoinductive material for bone regeneration.16 
Indeed, it is known that bone morphogenetic protein-2 
(BMP-2), one of the most potentially effective osteoinduc-
tive proteins able to boost bone formation and repair in 
vitro,17–20 is inherently present in, and released from, native 
dentin. Interestingly, since demineralization of highly min-
eralized tissues was found to increase BMP-2 bioavailabil-
ity,15 particular interest has been devoted to dentin in its 
demineralized form.21,22
In this work we have attempted to take a step forward 
towards the use of tooth derivatives. We herein propose 
deciduous teeth as potential grafting materials in bone aug-
mentation procedures. In particular, we examined the 
effects of the well-defined demineralizion protocol 
recently published;15 thus we analyzed the morphology 
and composition of demineralized baby teeth and com-
pared physico-chemical parameters with respect to those 
of their native counterparts. We also shed light on the 
effects of demineralization on deciduous teeth organic 
matter, evaluating whether or not collagen and BMP-2 
protein contents were preserved after the chemical treat-
ment. Moreover, we evaluated in vitro the response of 
osteoblastic cells to exogenous BMP-2 stimulation (at dif-
ferent protein concentrations) with the aim of identifying 
the minimum BMP-2 concentration able to induce the 
expression of alkaline phosphatase, the early marker of the 
osteoblastic phenotype.
Materials and methods
Materials and reagents
Demineralization and sterilization reagents were provided 
by TT Tooth Transformer S.r.l. (Milan, Italy). Enzyme-
linked immunosorbent assay (ELISA) kits (human type I 
collagen: SEA571Hu; human BMP-2: SEA013Hu) were 
purchased from Cloud-Clone Corp. (Katy, TX, USA). 
BCA protein assay kit was supplied by ThermoFisher 
(Monza, Italy). SAOS-2 (human osteogenic sarcoma cell 
line) cells were purchased from the American Type Culture 
Collection (ATCC, Manassas, VA, USA). AlamarBlue® 
cell viability assay was purchased from Life Technologies 
Italia (Monza, Italy), while an alkaline phosphatase activ-
ity (ALP) colorimetric assay kit was purchased from 
BioVision Inc. (Milpitas, CA, USA). All other chemicals 
were from Sigma-Aldrich (Milan, Italy) if not otherwise 
specified.
Sample preparation
Deciduous (baby) teeth (n = 3; obtained from one child 
undergoing deciduous tooth extraction) were provided 
by TT Transformer S.r.l. Human teeth were minced by 
means of a Tooth Transformer TT machine (TT Tooth 
Transformer S.r.l.) to give particles (hereafter referred to 
as BT) of Ø < 1 mm. Following mincing, BT particles 
were subjected to a demineralization and sterilization 
process according to a protocol previously described.15 
Briefly, particles were: i) demineralized using a demin-
eralization reagent, at 70° C under shaking by means of 
a thermomixer (1000 rev/min); ii) washed sequentially 
with two washing solutions at room temperature (RT) 
for 2 min; and iii) treated with a sterilization reagent at 
70° C under shaking by means of a thermomixer (1000 
rev/min). Particles were finally washed at R.T. for 2 min, 
twice. Demineralized BT particles (hereafter referred as 
to dBT) were next collected in sterile 1.5 mL polypro-
pylene tubes and stored at RT until use.
In control samples, BT particles were subjected to the 
same thermal process, but no chemical reagents were used, 
and deionized water (dH2O) was used, instead.
Evaluation of the effects of demineralization on 
BT morphology and composition
Analyses of the surface morphology of demineralized and 
control BT particles were performed with an environmen-
tal scanning electron microscope (ESEM Zeiss EVO50, 
Carl Zeiss, Milan, Italy) connected to a secondary electron 
detector for energy dispersive X-ray (EDS) analysis. 
Briefly, following 1.5% (v/v) glutaraldehyde fixation (2 h) 
and dehydration in gradual ethanol, samples were gold-
sputtered, mounted onto scanning electron microscopy 
(SEM) stubs and examined using an acceleration voltage 
of 15 kV. SEM images were acquired at ×5000 magnifica-
tion. EDS analysis was also performed to examine the sur-
face composition (elemental analysis, atomic percentage 
of carbon, C; nitrogen, N; phosphorus, P; and calcium, Ca) 
of three different particles from each group. EDS spectra 
refer to whole SEM pictures.
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Type I collagen and BMP-2 protein content 
quantification
Type I collagen (COL-I) and BMP-2 protein content in 
demineralized and control BT samples were quantified by 
ELISA.15 Briefly, following the thermal/demineralization 
treatment, ≈50 mg of both BT and dBT particles were 
transferred into 1.5 mL polypropylene tubes containing 
500 μL of extraction buffer (50 mM HEPES pH 7.4, 1 mM 
PMSF, 2 μg/mL leupeptin, 2 μg/mL aprotinin, 1 μg/mL 
pepstatin, and 1% (v/v) Triton X-100). After incubation at 
4° C overnight (ON), three freezing/thawing cycles, and 
sonication, proteins were extracted. Total protein content 
was determined by BCA protein assay kit according to the 
manufacturer’s instructions. For ELISA assays, 15 μg of 
total protein extracts (n ⩾ 4 per condition) were loaded 
and tests were carried out according to the manufacturer’s 
instructions. Absorbance was then measured at λ = 450 
nm using a GENios Plus reader (Tecan, Monza, Italy), and 
values were referred to an internal standard curve. Results 
from ELISAs were normalized to the weight of each sam-
ple (expressed as grams of sample particles).
Dose–response activity of exogenous BMP-2  
on osteoblast cell lines
Mycoplasm-free SAOS-2 cells were cultured in McCoy cul-
ture medium containing 1 mM sodium pyruvate, 100 U/mL 
penicillin, 0.1 mg/mL streptomycin, and 2 mM glutamine, 
and supplemented with 10% (v/v) FBS, at 37° C in a humid-
ified atmosphere under constant supply of 5% CO2.
Cells were seeded at a density of 3 × 104 cells/cm2 in 
a 96-well plate in 120 μL/well of culture medium enriched 
with exogenous BMP-2 at different concentrations (two-
fold serial dilution from 200 ng/mL to 0 ng/mL = unstim-
ulated CTRLs) (n = 4 per condition). Cells were cultured 
for three days, then cell viability and osteodifferentiation 
were evaluated. Specifically, cell viability was assessed 
using the AlamarBlue® assay. Briefly, the medium was 
removed and every well was loaded with 100 μL of spe-
cific medium containing 10% (v/v) of resazurin dye. 
Cells were incubated in standard culture conditions for 2 
h and the fluorescence of the medium was read by means 
of a GENios Plus reader (λex = 540 nm; λem = 595 nm). 
Viability of CTRL cells was designated as 100%. 
Osteodifferentiation was evaluated by means of the ALP 
activity colorimetric assay according to the manufactur-
er’s instructions. Briefly, at the end of the cell culture 
period, the supernatant from each well was recovered and 
assayed, evaluating the hydrolysis of nitrophenyl phos-
phate in the presence of secreted ALP enzyme. After 60 
min incubation at 25° C, the absorbance was read at λ = 
405 nm using a GENios Plus reader and values referred 
to an internal standard curve.
Statistical analysis
Statistical analysis was carried out by GraphPad version 
6 (GraphPad software, La Jolla, CA, USA). All data were 
initially analyzed using the D’Agostino and Pearson 
omnibus normality test. Comparisons among groups 
were performed by t-test. Significance was retained when 
p < 0.05. Data are expressed as mean ± standard devia-
tion (SD, n ⩾ 4).
Results and discussion
In recent decades, a great deal of effort has been devoted to 
the regeneration and de novo formation of bone tissue. 
Attempts included bone-grafting procedures, segmental 
bone transport, and the use of biomaterials for the augmen-
tation of alveolar bone defects.
We have recently proposed the use of tooth derivatives, 
namely demineralized dentin and enamel, as suitable sub-
strates for bone regeneration due to the inherent similarity 
of such materials to natural bone tissue.15,23 We have here 
focused our attention on deciduous baby teeth as a very 
promising, readily available source of bone-like tissue. 
Indeed, while most parts of the body are perennial from 
birth onwards, deciduous teeth are normally replaced and 
lost through the development and eruption of adult perma-
nent teeth (a process that starts at about six years and stops 
after 12 years of age). It is worthy of note that every year 
four million baby teeth fall out and customarily discarded. 
In addition, although primary teeth are of a smaller size 
and they contain less dentin and have a thinner enamel 
layer, baby teeth have the same basic structure as perma-
nent teeth, i.e. enamel, dentin, cementum, and pulpal 
(nerve) tissue. Therefore, they may represent a valuable 
biological alternative to the synthetic materials currently 
used in bone augmentations.
In this context, to the best of our knowledge, this is the 
first study focusing on the use of deciduous teeth to repair 
bone defects. In this work native and demineralized BT 
particles (Ø < 1 mm) were obtained by means of the 
Tooth Transformer TT machine, according to a protocol 
previously described.15 It is known that demineralization 
improves the in vivo resorption rate of highly mineralized 
materials while favoring their osteoconductivity and oste-
oinduction.13,22,24,25 We have thus evaluated the physico-
chemical features of demineralized deciduous teeth 
particles and compared such properties with those of 
native counterparts.
Demineralization effects on BT surface 
morphology and chemical composition
The tooth is, basically, a composite of organic constitu-
ents, such as collagen and other non-collagenous pro-
teins (e.g. BMPs), and inorganic components, including 
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five types of calcium phosphates (e.g. hydroxyapatite, 
HAp, and fluorapatite).23 Highly mineralized materials 
cannot be easily resorbed, thus limiting or even hamper-
ing their osteointegration and bone formation in 
vivo.13,24,25 In this light, demineralization was found to 
be very promising for overcoming such drawbacks 
through the improvement of the in vivo performance of 
tooth derivatives.26
In this study we evaluated the effects of the deminerali-
zation process on morphology and topography as well as 
on the chemical compositions of tooth particles by means 
of SEM/EDS analyses. As shown in Figure 1(a), the SEM 
image of native BT particles revealed the presence of min-
eral crystals studding the particle surface. The presence of 
an inorganic phase was confirmed by the analysis of the 
EDS spectrum reported in Figure 1(b), which displayed 
typical Ca and P peaks. As a result of a substantial removal 
of mineral components, SEM analyses revealed that dem-
ineralized BT samples (Figure 1(c)) had a smoother sur-
face, with more and wider dentin tubules when compared 
to native BT particles. EDS analyses confirmed these 
observations (Figure 1(d)). Indeed, the demineralization 
treatment led to a dramatic decrease in relative Ca and P 
content (%) of ≈75% with respect to the native BT parti-
cles, as reported in Table 1.
Overall, such findings are in agreement with those pre-
viously reported.15 It is noteworthy that the demineraliza-
tion process was very effective on the BT samples, and 
proved to be non-destructive on the protein components 
that were preserved after treatment.
Figure 1. SEM micrographs of (a) native and (c) demineralized baby tooth particles; and (b,d) their corresponding EDS spectra. 
White arrows point to dentinal tubules ((a) and (c)), while black arrows indicate mineral deposits (a). White scale bar ((a) and 
(c)) = 6 µm. Magnification: ×5000. x axis = Energy (keV); y axis = intensity (a.u.).
Table 1. Chemical composition of native and demineralized BT particles evaluated by EDS analysis.
Sample Carbon (%) Oxygen (%) Phosphorus (%) Calcium (%)
Native BT 22.1 55.4 8.5 12.9
Demineralized BT 66.1 28.3 2.1  3.3
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Demineralization effect on type I COL-I and 
BMP-2 protein content in BT
Although teeth are one of the most mineralized materials 
in the human body, they also contain organic components 
that are mostly collagenous proteins, type I collagen 
(COL-I) being the most abundant,27 and non-collagenous 
proteins, including bioactive growth factors (GFs) such as 
BMPs. It is well known that tooth collagen is more cross-
linked than bone collagen. This implies that tooth collagen 
is more favorably resistant than any other to thermal and 
chemical denaturation.28 On the other hand, the mineral 
matter has been shown to restrict the bioavailability of bio-
active molecules, such as BMPs,29 whereas the reduction 
of the mineral phase proved to favor their release.30 
Conversely, some reports have highlighted how some 
kinds of demineralization process may induce a dramatic 
damage to the tooth protein matrix.31,32
We thus shed light on the possible adverse effects of 
the demineralization process we applied to BT particles 
on the composition of the organic matrix in terms of 
COL-I and BMP-2 protein content. Besides, as proteins 
are only biologically functional if folded in a native-like 
fashion, we decided to quantify only the folded proteins. 
It is of note that the antibodies used in sandwich ELISAs 
targeted conformational rather than linear epitopes, which 
therefore allowed the detection of conformationally native 
COL-I and BMP-2 proteins and their quantification in BT 
particles.
The results from the ELISA tests are displayed in Figure 
2(a). It is of note that, irrespective of the demineralization, 
COL-I was invariably present in the BT particles. 
Specifically, we found a COL-I content of ≈3 ng per gram 
of BT particles (corresponding to ≈45 ng of COL-I per 
mL of total particle lysate) in both native and demineral-
ized particles. Such findings are in line with our previous 
data,15 and support the idea that the demineralization pro-
cess allows the preservation of the integrity of the tooth 
organic (protein) matrix.
It has also been reported that extensive demineralization 
may induce moderate to severe BMP depletion in teeth and 
other bone-like tissues.33 In line with this, Kim et al.13 
found undetectable levels of BMP-2 in tooth homogenates, 
probably because of the use of chemicals that had dena-
tured and/or depleted some tooth proteins. Instead, the 
demineralization process we have adopted allowed preser-
vation of the conformation and content of COL-I, one of 
the most important structural proteins of the extracellular 
matrix (ECM), and, by the same token, BMP-2, which is a 
bioactive molecule that plays a key role in osteoinduction. 
It is also worthy of note that significantly higher levels of 
BMP-2 were found in demineralized BT particles when 
compared with their native counterparts (Figure 2(b); 
p < 0.05). In more detail, demineralized BT contained 
1.2 ± 0.3 ng of BMP-2 per g of particles (corresponding to 
21.4 ± 6.2 ng of BMP-2 per mL of total particle lysate), 
which was roughly three-fold higher than the content found 
in native BT (0.42 ± 0.3 ng of BMP-2 per g of particles, 
corresponding to 8.7 ± 4.1 ng of BMP-2 per mL of total 
particle lysate). Again, our results support the idea that the 
demineralization process we used allowed an increase of 
the bioavailability of BMP-2 in tooth-derived materials; 
this in turn giving rise to more osteoinductive bone substi-
tutes.34 Interestingly, our data suggested that demineralized 
deciduous teeth contain much more BMP-2 with respect to 
native and demineralized dentin,15 which are currently con-
sidered to be among the most suitable substitutes used for 
bone repair and regeneration.25,35–37
Such findings all strengthen the idea that BTs are very 
attractive bioactive materials for use in autologous bone-
grafting procedures.
Effect of exogenous BMP-2 stimulation on 
osteodifferentiation
BMPs are members of the transforming grow factors beta 
(TGF-β) family, which play pivotal roles in the commit-
ment and differentiation of progenitor cells in the 
Figure 2. Protein quantification performed on native and demineralized baby tooth (BT) particles evaluated by ELISA assay. (a) 
COL-I; (b) BMP-2. Protein content was normalized with respect to the weight of each sample (expressed as grams of sample 
particles). Data are expressed as mean ±SD. * p < 0.05.
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osteoblastic lineage.38,39 Among BMPs, BMP-2 is a potent 
trigger in vitro and in vivo.40 While osteodifferentiation is 
fundamental for normal bone development, it is important 
with respect to bone repair strategies as well. In this regard, 
the development of clinically relevant materials able to 
promote osteointegration and de novo bone tissue forma-
tion, such as those inherently containing a considerable 
amount of BMP-2, is of capital interest and utmost 
importance.
As we are aware, in this study we evaluated the dose–
response effects of BMP-2 on the ostedifferentiation of 
osteoblastic cells in vitro. We thus challenged SAOS-2 cell 
cultures with exogenously added BMP-2. Upregulation of 
endogenous cellular ALP is a widely used marker for the 
assessment of cell differentiation into the osteoblastic phe-
notype.41 As shown in Figure 3, the stimulation of SAOS-2 
cells for three days with variable doses of BMP-2 protein 
induced a dose-dependent increase in ALP activity. The 
minimum concentration of BMP-2 able to induce a signifi-
cant upregulation of ALP protein was 12.5 ng/mL (Figure 
3(c); p < 0.05 with respect to unstimulated controls), cor-
responding to an increase of ≈1.5-fold over unstimulated 
controls (i.e. 0 ng/mL of BMP-2). As expected, the maxi-
mum ALP activity was found when cells were stimulated 
with 200 ng/mL of BMP-2, corresponding of a ≈1.75-fold 
increase in ALP levels with respect to controls. Viability of 
stimulated cells was also comparable with that of unstimu-
lated cells. This is a very intriguing result because it points 
out that the differences in ALP activity mirrored the real 
osteodifferentiation of cultured cells (Figure 3(a) and (b)), 
instead of their mere overgrowth. Such data are in good 
agreement with previous observations in other cell lines.41
On the basis of ALP activity as a function of the BMP-2 
dose used to stimulate cells, we can speculate that the 
BMP-2 content found in demineralized BT, correspond-
ing to a concentration of ≈22 ng of BMP-2 per mL of 
total particle lysate, is very effective in inducing cell 
osteodifferentiation.
Conclusions
In recent years there has been growing interest in teeth and 
tooth derivatives as valuable alternatives to synthetic bio-
materials for bone-grafting and replacement procedures. 
In this context, due to their high similarity to bone tissue 
and their wide availability, deciduous baby teeth are 
very promising candidates for the augmentation or repair 
of alveolar bone defects. On the other hand, highly 
Figure 3. (a), (b) Evaluation of osteodifferentiation using alkaline phosphatase (ALP) activity assay of SAOS-2 cells after three days 
of culture upon exogenous BMP-2 stimulation. Data are expressed as means ±SEM in terms of: (a) arbitrary units of fluorescence 
(RFU) normalized to the total protein content in each sample; (b) fold-increase. * p < 0.05. (c), (d) Evaluation of SAOS-2 cells 
viability after three days of culture upon exogenous BMP-2 stimulation. Unstimulated SAOS-2 cells were used as internal reference 
(i.e. positive controls for cell growing, denominated as CTRL; 100% cell viability). Data are expressed as means ±SD in terms of: (a) 
arbitrary units of fluorescence (RFU); as well as (b) percentage of cell viability with respect to the CTRL.
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mineralized natural biomaterials, such as teeth, bone, and 
bone-derived materials, display unsuitably low resorption 
rates in vivo. In this study, we thus propose the use of dem-
ineralized BTs as osteoinductive substrates for bone regen-
eration and replacement. Demineralized BTs were 
thoroughly characterized by SEM/EDS analyses and com-
pared to native teeth. It is of note that the demineralization 
process we used did not damage tooth microstructure. 
Indeed, the organic content was preserved in demineral-
ized deciduous teeth, as demonstrated by ELISA assay 
used to quantify COL-I content. Interestingly, the demin-
eralization process allowed an increase of the BMP-2 bio-
availability in treated BTs, as compared to the untreated 
counterparts. The BMP-2 content found in demineralized 
BT also proved to be very effective in enhancing ALP 
activity, thus in osteodifferentiating SAOS-2 cells in vitro, 
as confirmed by cell experiments performed upon exoge-
nously added BMP-2. With this perspective, deciduous 
teeth are very promising candidates as bone substitutes for 
bone repair and replacement. In this light, in vivo investi-
gation is thus urged to strengthen our findings and to shed 
light on the performance of BTs for bone grafts in vivo.
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